Use of Rosuvastatin in Preventing Vascular Events in Patients with Elevated C-Reactive Protein

被引：1
|
作者：
Guthrie, Robert M. [1 ,2 ,3 ]
机构：
[1] Ohio State Univ, Dept Emergency Med, Columbus, OH 43210 USA
[2] Ohio State Univ, Dept Internal Med, Columbus, OH 43210 USA
[3] Ohio State Univ, Dept Pharmacol, Columbus, OH 43210 USA
来源：
POSTGRADUATE MEDICINE | 2010年 / 122卷 / 02期
关键词：
D O I：
10.3810/pgm.2010.03.2136
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：169 / 171
页数：3
相关论文
共 50 条
  • [1] Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein
    Kozlowski, Blazej
    Narkiewicz, Krzysztof
    [J]. KARDIOLOGIA POLSKA, 2009, 67 (03) : 344 - 347
  • [2] Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein
    James K. Liao
    [J]. Current Atherosclerosis Reports, 2009, 11 (4) : 243 - 244
  • [3] Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein
    Ridker, Paul M.
    Danielson, Eleanor
    Fonseca, Francisco A. H.
    Genest, Jacques
    Gotto, Antonio M., Jr.
    Kastelein, John J. P.
    Koenig, Wolfgang
    Libby, Peter
    Lorenzatti, Alberto J.
    MacFadyen, Jean G.
    Nordestgaard, Borge G.
    Shepherd, James
    Willerson, James T.
    Glynn, Robert J.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2008, 359 (21): : 2195 - 2207
  • [4] Rosuvastatin in Patients with Elevated C-Reactive Protein Reply
    Ridker, Paul M.
    Glynn, Robert J.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2009, 360 (10): : 1041 - 1042
  • [5] Rosuvastatin prevented major cardiovascular events in persons with elevated C-reactive protein
    Campbell-Scherer, Denise L.
    Montori, Victor M.
    [J]. ANNALS OF INTERNAL MEDICINE, 2009, 150 (02)
  • [6] COST-EFFECTIVENESS OF ROSUVASTATIN FOR THE PRIMARY PREVENTION OF VASCULAR EVENTS ACCORDING TO FRAMINGHAM RISK SCORE IN PATIENTS WITH AN ELEVATED C-REACTIVE PROTEIN
    MacDonald, G. P.
    [J]. VALUE IN HEALTH, 2010, 13 (03) : A163 - A163
  • [7] Cost-Effectiveness of Rosuvastatin for Primary Prevention of Cardiovascular Events According to Framingham Risk Score in Patients With Elevated C-Reactive Protein
    MacDonald, Gary P.
    [J]. JOURNAL OF THE AMERICAN OSTEOPATHIC ASSOCIATION, 2010, 110 (08): : 427 - 436
  • [8] Genetically elevated C-reactive protein and ischemic vascular disease
    Zacho, Jeppe
    Tybjaerg-Hansen, Anne
    Jensen, Jan Skov
    Grande, Peer
    Sillesen, Henrik
    Nordestgaard, Borge G.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2008, 359 (18): : 1897 - 1908
  • [9] Genetically Elevated C-Reactive Protein and Vascular Disease.
    Bubb, Michael R.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2009, 360 (09): : 933 - 934
  • [10] Genetically elevated C-reactive protein and ischemic vascular disease
    James K. Liao
    [J]. Current Atherosclerosis Reports, 2009, 11 (4) : 245 - 245
12345